From December’s announcement of plans to fully acquire OneOncology to its closing, Cencora’s pace of bringing the physician-owned platform into the fold can only be described one way: accelerated. OneOncology’s growth makes investors move sooner rather than later, said Jeff Patton, MD, the CEO of OneOncology and former CEO of Tennessee Oncology, one of the platform’s founding practices. In an interview with The American Journal of Managed Care® (AJMC®) following the closing, Patton described the alignment OneOncology enjoys with Cencora, known largely as a drug wholesale and distribution company.
Read the full article: As Cencora Closes with OneOncology, Patton Says Terms Show “Trust” //
Source: https://www.ajmc.com/view/as-cencora-closes-with-oneoncology-patton-says-terms-show-trust-